GenSight Biologics Announces the Closing of its Nearly €1.7 Million Fundraising

GenSight Biologics Announces Successful Fundraising Worth Nearly €1.7 Million

GenSight Biologics Provides Updates about GS010/LUMEVOQ® Early Access Programs and the Ongoing REVISE Study

GenSight Biologics Reports Cash Position as of December 31, 2025, and Provides Business Updates

GenSight Biologics Announces Closing of Fundraising Worth Nearly EUR 2.9 Million

GenSight Biologics Announces Successful Fundraising Amounting to Nearly €2.9 Million

GenSight Biologics Announces Closing of Fundraising Worth Nearly EUR 2 Million

GenSight Biologics Announces Successful Fundraising Amounting to Nearly €2 Million

GenSight Biologics Reports Cash Position as of September 30, 2025

GenSight Biologics Announces Closing of Fundraising Worth Nearly EUR 3.7 Million